Live MPS Pharmaa Share Price Chart

O 3.21

H 3.21

L 3.21

VOL 100

MPS Pharmaa Performance

Days Range

Low: ₹3.05
High: ₹3.21
Previous Close ₹3.21
Open ₹3.21
Volume 39,264
Day’s Range ₹3.05 - ₹3.21
52W Range ₹2.10 - ₹3.21
Market Cap ₹6.13 Cr

MPS Pharmaa Fundamentals

ROCE (TTM) -10.2348
P/E Ratio (TTM) 0
P/B Ratio 2.53
Industry P/E 46.02
Debt to Equity 2.91
ROE -39.015
EPS (TTM) 0
Dividend Yield 0
Book Value 1.27
Face Value 10

MPS Pharmaa Financials

Mar 2023Jun 2023Sep 2023Dec 2023
Net Sales0000
Expenses0.350.230.250.22
Profit before tax-0.32-0.19-0.19-0.22
Operating Profit-0.32-0.19-0.18-0.21
Net Profit-0.32-0.19-0.18-0.21
EPS in Rs-0.16-0.1-0.1-0.11

About MPS Pharmaa

MPS Pharmaa Limited (Formerly known Advik Laboratories Limited) was incorporated in September, 1994. The Company was promoted in by the Jains along with a group of dedicated professionals. Presently, ... Read More

Parent Organisation Indian Private
Founded 1994
Managing Director
BSE Symbol ADVIKLA

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹3,061.97

373.45

7.20 (-1.89%)

372.3 - 384.4View Peer Comparison
Celestial Biolabs Ltd ₹4.56

1.75

0.00 (0.00)

1.75 - 1.8View Peer Comparison
JFL Life Sciences Ltd ₹48.06

43

0.70 (-1.60%)

40 - 43View Peer Comparison
Procter & Gamble Health Ltd ₹7,964.60

4777.1

29.70 (-0.62%)

4752.05 - 4835.9View Peer Comparison
Veerhealth Care Ltd ₹46.30

26

0.00 (0.00)

26 - 26View Peer Comparison

What's Trending

MPS Pharmaa FAQs

What is the Share price of MPS Pharmaa (ADVIKLA)?

MPS Pharmaa (ADVIKLA) share price as of April 8, 2024, on BSE is Rs 3.21 (BSE).

Can I buy MPS Pharmaa (ADVIKLA) shares?

Yes, You can buy MPS Pharmaa (ADVIKLA) shares by opening a Demat account with Angel One.

How do I buy MPS Pharmaa (ADVIKLA) from Angel One?

MPS Pharmaa (ADVIKLA) share can be brought through the following modes:
  1. Direct investment: You can buy MPS Pharmaa (ADVIKLA) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to MPS Pharmaa (ADVIKLA) shares.